Volume 34, 16 May 2003 | 05/2003 |
SPOT ON | |
CONVINCE Study: Early Stop for Commercial Reasons Unethical | |
NEW ON THE MARKET | |
Cox-2 Inhibitor Valdecoxib (BEXTRA) | |
REVIEW | |
Treatment of Atopic Dermatitis (II): Further Therapeutic Interventions | |
a-t READERS' QUESTIONS AND COMMENTS |
|
OMACOR After Myocardial Infarction? | |
IN BRIEF | |
Menopausal Hormone Replacement Without Effect on Quality of Life | |
CURRENT ADR NETWORK REPORT | |
Slow-Onset Myopathy Due to Statins | |
SIDE EFFECTS | |
Fatalities After Hexavalent Vaccines (HEXAVAC, INFANRIX HEXA) | |
© arznei-telegramm 05/2003 | ||